The Conjugation and Labeling Services Market is projected to grow at a CAGR of 10%, till 2035, according to a new market research report by Roots Analysis

News provided by

Sep 12, 2023, 10:25 ET

The complexities associated with conjugation of biomolecules and the need for click-chemistry expertise have prompted the pharmaceutical industry to rely on conjugation and labeling service providers

LONDON, Sept. 12, 2023 /PRNewswire/ -- Roots Analysis has announced the addition of "Conjugation and Labeling Services Market, 2023-2035" report to its list of offerings.

A number of drug developers and research institutes currently lack the technical expertise related to bioconjugation chemistries, along with limited in-house capabilities and scarcity of advanced bioconjugation technologies, which are essential to carry out the process of conjugation. In order to leverage the relevant experience and expertise of service providers, several organizations prefer to outsource their antibody conjugation services and protein labeling operations. Additionally, various stakeholders have been making consolidated efforts to forge alliance with other industry / non-industry players. It is worth highlighting that, since 2018, over 70 strategic partnerships have been inked, indicating that service providers are actively upgrading their conjugation related capabilities and accommodating the current and anticipated demand for bioconjugates. In fact, in July 2023, Novartis announced the acquisition of DTx Pharma with an aim to utilize its proprietary FALCON platform to develop siRNA therapies that can be used for the treatment of various neurological indications.

To order this 220+ page report, which features 60+ figures and 70+ tables, please visit our report on Conjugation and Labelling Services Market

Key Market Insights

At present, more than 240 companies across the globe claim to have the required capabilities to offer a range of conjugation and labeling services for various biomolecules
Over 40% of the service providers offer conjugation and labeling services for both proteins and antibodies; of these, nearly 80% have the capability to conjugate / label haptens with these biomolecules
In order to cater to the evolving needs of clients, several service providers claim to be steadily expanding their existing capabilities to enhance their respective service portfolio
The growing interest of stakeholders in conjugation and labeling domain is also reflected by the increasing number of partnerships established by various international and indigenous players
Over the years, industry stakeholders and researchers have been participating in several global events to share ideas, discuss the research outcomes and develop a better understanding of the bioconjugation domain
The market is likely to grow at a CAGR of ~10% over the next decade, the projected opportunity is anticipated to be well distributed across different types of molecules, conjugates / labels and key geographical regions

For more information, please visit https://www.rootsanalysis.com/reports/conjugation-and-labeling-services-market.html

The financial opportunity within the conjugation and labeling services market has been analyzed across the following segments:

Type of Molecule

Proteins
Peptides
Small Molecules
Antibodies
Other Molecules

Type of Molecular Conjugate / Label

Polymers
Haptens
Enzymes
Fluorescent Tags
Bead Coupling / Particle Conjugates
Quantum Dots
Isotopes
Other Molecular Conjugates / Labels

Key Geographical Regions

North America
Europe
Asia-Pacific
Middle East and North Africa
Latin America

The opinions and insights presented in the report were influenced by discussions held with stakeholders in this domain. The report features detailed transcripts of interviews held with the following industry stakeholders:

Sudhirdas Prayaga (President and Chief Executive Officer, Antibody Research)
Vishal Rai (Founder, Plabeltech)
Alastair Dent (Managing Director and Quality Director, Fleet Bioprocessing)

The research includes brief profiles of key players (listed below) offering conjugation and labeling services; each profile features a brief overview of the company, recent developments and an informed future outlook.

AltaBioscience
Bachem
Bio-Synthesis
Cayman Chemical
CliniSciences
Eurogentec
GBI
Mimotopes
Peptide Institute
piCHEM

Key Questions Answered

What is the global market size of antibody conjugation services market?
Which are the leading companies in the antibody conjugation services market?
How many companies offer peptide conjugation services?
What percentage of service providers are engaged in offering conjugation and labeling services with both fluorescent tags and enzymes?
How many service providers offer services related to antibody-enzyme bioconjugation?
What are the major factors driving the conjugation and labeling services market?
What are the leading market segments in the conjugation and labeling services market?
Which region captures the highest share in the conjugation and labeling services market?
What is the likely growth rate (CAGR) for conjugation and labeling services market?

Table of Contents